SELLAS Life Sciences Group, Inc.
SLS
$1.92
$0.0955.22%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 11.63% | 39.23% | 17.20% | 23.30% | 15.50% |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 37.71% | 6.19% | -16.64% | -22.11% | -29.55% |
Change in Net Operating Assets | 48.62% | -116.09% | -134.88% | -171.11% | -544.37% |
Cash from Operations | 24.29% | 15.71% | -48.25% | -13.26% | -27.97% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 921.74% | -11.50% | -97.89% | 36,362.96% | -- |
Repurchase of Common Stock | -- | -- | -106.45% | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 921.74% | -11.50% | -99.76% | 36,362.96% | 1,527.59% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 66.55% | -8.65% | -396.53% | 220.80% | 8.19% |